Michael J Berna

Michael J Berna

Eli Lilly and Company - Indianapolis / United States
Medical and Health Sciences / Biochemistry
AD Scientific Index ID: 4387362
-
person_outline Michael J Berna's MOST POPULAR ARTICLES
1-) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptorAC Porter, JM Sauer, MD Knierman, GW Becker, MJ Berna, J Bao, ...Journal of Pharmacology and Experimental Therapeutics 301 (3), 1020-1024, 20027832002
2-) Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkersBL Ackermann, MJ BernaExpert review of proteomics 4 (2), 175-186, 20072062007
3-) Quantitative analysis of amyloid β peptides in cerebrospinal fluid of Alzheimer\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s disease patients by immunoaffinity purification and stable isotope dilution liquid …T Oe, BL Ackermann, K Inoue, MJ Berna, CO Garner, V Gelfanova, ...Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 20061782006
4-) Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discoveryBL Ackermann, MJ Berna, AT MurphyCurrent Topics in Medicinal Chemistry 2 (1), 53-66, 20021762002
5-) Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosisMJ Berna, Y Zhen, DE Watson, JE Hale, BL AckermannAnalytical chemistry 79 (11), 4199-4205, 20071152007